{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Katie", "organization": "", "rank": 1, "lastname": "THOMAS"}], "original": "By KATIE THOMAS"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Food and Drug Admin settles case with Amarin, granting company leeway to promote drug Vascepa for uses that have not yet been approved; deal could have wider effect on how some drugs are marketed.  ", "multimedia": [{"type": "image", "url": "images/2016/03/08/business/0309vascepa/0309vascepa-thumbWide.jpg", "legacy": {"wide": "images/2016/03/08/business/0309vascepa/0309vascepa-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/03/08/business/0309vascepa/0309vascepa-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/08/business/0309vascepa/0309vascepa-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "776"}, "width": 600, "subtype": "xlarge", "height": 776}, {"type": "image", "url": "images/2016/03/08/business/0309vascepa/0309vascepa-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/08/business/0309vascepa/0309vascepa-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "Deal Allows Promotion of Off-Label Use of Drug", "main": "F.D.A. Deal Allows Amarin to Promote Drug for Off-Label Use"}, "print_page": "1", "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Advertising and Marketing", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Amarin Corp PLC", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Freedom of Speech and Expression", "is_major": "N", "rank": "5", "name": "subject"}], "snippet": "The Food and Drug Administration will now allow Amarin to sell Vascepa, an omega-3 fatty acid, for both high and low triglyceride levels.", "source": "The New York Times", "lead_paragraph": "The Food and Drug Administration will now allow Amarin to sell Vascepa, an omega-3 fatty acid, for both high and low triglyceride levels.", "word_count": "720", "pub_date": "2016-03-09T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/03/09/business/fda-deal-allows-amarin-to-promote-drug-for-off-label-use.html", "_id": "56df7ee738f0d836dc035a08"}